← Back to Search

Other

UC intervention diet for Ulcerative Colitis

N/A
Waitlist Available
Research Sponsored by Mount Sinai Hospital, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a special diet made up of regular foods to help people with mild to moderately active ulcerative colitis. The goal is to change the types of bacteria in their gut to reduce inflammation and symptoms. By eating certain foods, the diet aims to promote 'good' bacteria and decrease 'bad' bacteria.

Eligible Conditions
  • Ulcerative Colitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in microbiome composition
Change in microbiome function
Secondary study objectives
Decrease in clinical disease activity
Decrease in endoscopic disease activity

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Ulcerative colitis patients with mild to moderate activityExperimental Treatment1 Intervention
Participants will be followed for 14 days on their traditional diet followed by an 8 week intervention with the specially designed and provided treatment diet.

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,450 Previous Clinical Trials
4,332,497 Total Patients Enrolled
15 Trials studying Ulcerative Colitis
3,773 Patients Enrolled for Ulcerative Colitis
Mount Sinai Hospital, CanadaLead Sponsor
203 Previous Clinical Trials
69,277 Total Patients Enrolled
8 Trials studying Ulcerative Colitis
1,419 Patients Enrolled for Ulcerative Colitis

Media Library

UC intervention diet (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04121806 — N/A
Ulcerative Colitis Research Study Groups: Ulcerative colitis patients with mild to moderate activity
Ulcerative Colitis Clinical Trial 2023: UC intervention diet Highlights & Side Effects. Trial Name: NCT04121806 — N/A
UC intervention diet (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04121806 — N/A
~4 spots leftby Dec 2025